Statements (19)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:chemical_compound
|
gptkbp:alsoKnownAs |
gptkb:Almorexant
|
gptkbp:ATCCode |
none
|
gptkbp:CASNumber |
gptkb:459789-99-2
|
gptkbp:developedBy |
gptkb:Actelion
|
gptkbp:drugClass |
orexin receptor antagonist
|
gptkbp:hasMolecularFormula |
C17H27N5O2
|
gptkbp:hasSMILES |
CC(C)[C@@H](C(=O)N)NC(=O)C1=NC=NC2=C1N=CN2CC3CCCCC3
|
gptkbp:hasUNII |
6Z5B6HVF6O
|
https://www.w3.org/2000/01/rdf-schema#label |
459789-99-2
|
gptkbp:IUPACName |
gptkb:N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-imidazole-4-carboxamide
|
gptkbp:molecularWeight |
333.43 g/mol
|
gptkbp:PubChem_CID |
9933476
CHEMBL2103887 DB06699 |
gptkbp:status |
development discontinued
|
gptkbp:bfsParent |
gptkb:obeticholic_acid
gptkb:奥贝胆酸 |
gptkbp:bfsLayer |
6
|